Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Borana Weaves IPO opens for subscription with healthy GMP. Should you bid ?
20/05/2025
How will higher anchor investor allocation impact lower rated bond market ?
20/05/2025
Sebi updates audit committee norms for MIIs
20/05/2025
RBI accepts lower bond purchase amount in first FY26 OMO auction
20/05/2025
Protean eGov Technologies shares plunge 20% after downgrade amid PAN 2.0 project withdrawal
20/05/2025
How will Resonac's plant closures impact the global graphite market ?
20/05/2025
